tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2023 Feb 24;11(3):541.
doi: 10.3390/vaccines11030541.
A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously
Usman Saeedullah[SUP] 1 [/SUP], Anas M Abbas[SUP] 2 [/SUP], Caitlin Ward[SUP] 2 [/SUP], Maha Bayya[SUP] 2 [/SUP], Jenish Bhandari[SUP] 2 [/SUP], Araf M Abbas[SUP] 3 [/SUP], Joshua DeLeon[SUP] 1 [/SUP], Allison B Reiss[SUP] 1 [/SUP]
Affiliations
Abstract
The ongoing coronavirus disease 2019 (COVID-19) pandemic may result in cardiovascular complications such as myocarditis, while encephalitis is a potentially life-threatening COVID-19-associated central nervous system complication. This case illustrates the possibility of developing severe multisystem symptoms from a COVID-19 infection, despite having received the COVID-19 vaccine within the year. Delay in treatment for myocarditis and encephalopathy can lead to permanent and possibly fatal damage. Our patient, a middle-aged female with a complicated medical history, initially came in without characteristic manifestations of myocarditis such as shortness of breath, chest pain, or arrhythmia, but with an altered mental status. Through further laboratory tests, the patient was diagnosed with myocarditis and encephalopathy, which were resolved within weeks through medical management and physical/occupational therapy. This case presentation describes the first reported case of concomitant COVID-19 myocarditis and encephalitis after receiving a booster dose within the year.
Keywords: ACE-2; COVID-19; Takutsobo; dilated cardiomyopathy; encephalopathy; myocarditis.
. 2023 Feb 24;11(3):541.
doi: 10.3390/vaccines11030541.
A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously
Usman Saeedullah[SUP] 1 [/SUP], Anas M Abbas[SUP] 2 [/SUP], Caitlin Ward[SUP] 2 [/SUP], Maha Bayya[SUP] 2 [/SUP], Jenish Bhandari[SUP] 2 [/SUP], Araf M Abbas[SUP] 3 [/SUP], Joshua DeLeon[SUP] 1 [/SUP], Allison B Reiss[SUP] 1 [/SUP]
Affiliations
- PMID: 36992125
- DOI: 10.3390/vaccines11030541
Abstract
The ongoing coronavirus disease 2019 (COVID-19) pandemic may result in cardiovascular complications such as myocarditis, while encephalitis is a potentially life-threatening COVID-19-associated central nervous system complication. This case illustrates the possibility of developing severe multisystem symptoms from a COVID-19 infection, despite having received the COVID-19 vaccine within the year. Delay in treatment for myocarditis and encephalopathy can lead to permanent and possibly fatal damage. Our patient, a middle-aged female with a complicated medical history, initially came in without characteristic manifestations of myocarditis such as shortness of breath, chest pain, or arrhythmia, but with an altered mental status. Through further laboratory tests, the patient was diagnosed with myocarditis and encephalopathy, which were resolved within weeks through medical management and physical/occupational therapy. This case presentation describes the first reported case of concomitant COVID-19 myocarditis and encephalitis after receiving a booster dose within the year.
Keywords: ACE-2; COVID-19; Takutsobo; dilated cardiomyopathy; encephalopathy; myocarditis.